Ranked in 1 Practice Areas
3

Band 3

About

Provided by Julie Tibbets

USA

Practice Areas

Julie Tibbets chairs Goodwin’s Life Sciences Regulatory & Compliance practice at the firm and co-chairs Goodwin’s Rare Disease Initiative. In addition, she co-chairs Goodwin’s firmwide Attorney Review Committee.

Julie focuses her practice on FDA-regulated product development, clinical research, product marketing and enforcement as well as the intersection of each of those with corporate strategy and securities disclosure obligations. Her product areas of focus include biologics, drugs, medical devices, digital therapeutics, clinical decision support tools and mobile medical apps. She also leads the regulatory due diligence reviews of FDA-regulated M&A or investment targets, potential collaborators, and licensees, and guides the regulatory disclosures of FDA-regulated entities in their initial public offerings and follow-on offerings. Julie also works closely with the Food & Healthy Living practice team at Goodwin on the intersection of food, supplement, and cosmetic regulation with FDA’s drug and device authorities.

Personal

JD, University of North Carolina, Chapel Hill 2004 (Member, Law Review); BA, Purdue University 2001 (Highest Honors, Phi Beta Kappa).

Chambers Review

Provided by Chambers

Chambers Guide to the USA

Healthcare: Pharmaceutical/Medical Products Regulatory - District of Columbia

3
Band 3
Individual Editorial
Julie Tibbets has a dynamic regulatory practice focusing on pharmaceutical and medical products.

Strengths

Provided by Chambers

Discover other Lawyers at
Goodwin

Provided by Chambers
Filter by
Band

California

Banking & Finance

3
Kristopher Ring
3
Band 3
5
Dylan Brown
5
Band 5
Capital Markets: Debt & Equity

2
Bradley Weber
2
Band 2
4
Maggie L Wong
4
Band 4
Intellectual Property: Patent Prosecution

2
Michael J Shuster
2
Band 2
4
Kevin Kabler
4
Band 4
Labor & Employment

4
Koray Bulut
4
Band 4
Life Sciences: Corporate/Commercial

3
Maggie L Wong
3
Band 3
3
Sam Zucker
3
Band 3
3
Shane Albright
3
Band 3
Life Sciences: IP/Patent Litigation

2
Michael J Shuster
2
Band 2
Litigation: Securities

3
Jonathan Shapiro
3
Band 3
Litigation: White-Collar Crime & Government Investigations

2
Grant P Fondo
2
Band 2
Private Equity: Buyouts

4
Brian C. McPeake
4
Band 4
4
Stephen Lee
4
Band 4
Venture Capital

1
Anthony McCusker
1
Band 1
3
Caine Moss
3
Band 3
Venture Capital: Fund Formation

2
Ian O'Donnell
2
Band 2

California: Northern

Real Estate

3
Dustin Calkins
3
Band 3
Tax

3
Kelsey Lemaster
3
Band 3
20 of 178 results